DrugPatentWatch Database Preview
Litigation Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)
» See Plans and Pricing
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)
| Docket | Start Trial | Date Filed | 2018-05-07 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,071,977; 10,149,829; 9,060,995; 9,539,234; 9,549,913; 9,730,910; 9,855,241; RE46,604 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-03 | 114 | Notice of Service | U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-12-10 | 115 | Notice of Service | Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to Teva; and (2) Vanda's Supplemental Infringement…Infringement Contentions for U.S. Patent No. 10,071,977 to MSN filed by Vanda Pharmaceuticals Inc..(Fahnestock… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-12-23 | 118 | Notice of Service | Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity …Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions … 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
